V, K., J, O., E, F., J, Y., AN, E., RB, L., . . . LC, C. (2026). Pharmacological inhibition of sclerostin protects bone from B-cell acute lymphoblastic leukemia-mediated destruction. HemaSphere, 10(4), e70355. https://doi.org/10.1002/hem3.70355
Chicago Style (17th ed.) CitationV, Kuek, Oommen J, Ferrari E, Yuan J, Economides AN, Lock RB, Malinge S, Kotecha RS, and Cheung LC. "Pharmacological Inhibition of Sclerostin Protects Bone from B-cell Acute Lymphoblastic Leukemia-mediated Destruction." HemaSphere 10, no. 4 (2026): e70355. https://doi.org/10.1002/hem3.70355.
MLA (9th ed.) CitationV, Kuek, et al. "Pharmacological Inhibition of Sclerostin Protects Bone from B-cell Acute Lymphoblastic Leukemia-mediated Destruction." HemaSphere, vol. 10, no. 4, 2026, p. e70355, https://doi.org/10.1002/hem3.70355.